Recommendations for the Use of Abatacept in Patients with rheumatoid Arthritis

被引：0
|
作者：
Gaubitz, M. [1 ]
Krueger, K. [2 ]
Haas, J. -P. [3 ]
机构：
[1] WWU Munster, Akad Manuelle Therapie, Munster, Germany
[2] Praxiszentrum, D-81541 Munich, Germany
[3] Kinderklin Garmisch Partenkirchen, Deutsch Zentrum Kinder & Jugendrheumatol, Garmisch Partenkirchen, Germany
来源：
ZEITSCHRIFT FUR RHEUMATOLOGIE | 2014年 / 73卷 / 10期
关键词：
JUVENILE IDIOPATHIC ARTHRITIS; COSTIMULATION MODULATOR ABATACEPT; LONG-TERM SAFETY; INADEQUATE RESPONSE; DOUBLE-BLIND; PHASE IIIB; SUBCUTANEOUS ABATACEPT; BIOLOGICAL AGENTS; GERMAN SOCIETY; AIM TRIAL;
D O I：
10.1007/s00393-014-1373-4
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：942 / 949
页数：8
相关论文
共 50 条
  • [1] Abatacept use in rheumatoid arthritis: Evidence review and recommendations
    Martin Mola, Emilio
    Balsa, Alejandro
    Martinez Taboada, Victor
    Sanmarti, Raimon
    Luis Marenco, Jose
    Navarro Sarabia, Federico
    Gomez-Reino, Juan
    Alvaro-Gracia, Jose Maria
    Roman Ivorrai, Jose Andres
    Lojo, Leticia
    Plasencia, Chamaida
    Carmona, Loreto
    REUMATOLOGIA CLINICA, 2013, 9 (01): : 5 - 17
  • [2] Use of abatacept in rheumatoid arthritis Recommendations based on current evidence
    von Kempis, Johannes
    Dudler, Jean
    Hasler, Paul
    Kyburz, Diego
    Tyndall, Alan
    Zufferey, Pascal
    Villiger, Peter M.
    SWISS MEDICAL WEEKLY, 2012, 142
  • [3] Recommendations for use of abatacept in patients with rheumatoid arthritis [Empfehlungen zum Einsatz von Abatacept bei Patienten mit rheumatoider Arthritis]
    Gaubitz M.
    Krüger K.
    Haas J.-P.
    Zeitschrift für Rheumatologie, 2014, 73 (10) : 942 - 949
  • [4] Recommendations for use of rituximab in patients with rheumatoid arthritis
    Rubbert-Roth, A.
    Burmester, G. R.
    Doerner, T.
    Gause, A.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2014, 73 (02): : 165 - +
  • [5] Recommendations on the use of rituximab for patients with rheumatoid arthritis
    Rubbert-Roth, A.
    Burmester, G.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2008, 67 (07): : 609 - 613
  • [6] Use of tocilizumab, abatacept or rituximab in rheumatoid arthritis
    Fahd, A.
    Noone, C.
    Stack, J.
    Daly, M.
    Eltahir, A.
    Harney, S.
    Ryan, J. G.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2011, 180 : S199 - S199
  • [7] Update on the use of abatacept for the treatment of rheumatoid arthritis
    Vicente Rabaneda, Esther F.
    Herrero-Beaumont, Gabriel
    Castaneda, Santos
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2013, 9 (07) : 599 - 621
  • [8] Canadian Recommendations for Use of Methotrexate in Patients with Rheumatoid Arthritis
    Katchamart, Wanruchada
    Bourre-Tessier, Josiane
    Donka, Timea
    Drouin, Julie
    Rohekar, Gina
    Bykerk, Vivian P.
    Haraoui, Boulos
    Leclerq, Sharon
    Mosher, Dianne P.
    Pope, Janet E.
    Shojania, Kam
    Thomson, John
    Thorne, J. Carter
    Bombardier, Claire
    JOURNAL OF RHEUMATOLOGY, 2010, 37 (07) : 1422 - 1430
  • [9] EFFECTS OF ABATACEPT ON MONOCYTES IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Bonelli, M.
    Ferner, E.
    Savitskaya, A.
    Blueml, S.
    Steiner, C-W
    Rath, E.
    Smolen, J. S.
    Scheinecker, C.
    ANNALS OF THE RHEUMATIC DISEASES, 2010, 69 : A67 - A67
  • [10] Abatacept for rheumatoid arthritis
    Thorley, Jennifer
    LANCET RHEUMATOLOGY, 2020, 2 (03): : E134 - E134
12345